NCT01539980View on ClinicalTrials.gov

Clinical Study on Silk Sericin Wound Dressing for Split-thickness Skin Graft Donor Sites Treatment

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

April 30, 2014

Conditions
Late Complication From Skin GraftInfection of Skin Donor SiteImpaired Wound HealingPain, Intractable
Interventions
DEVICE

Sericin scaffold

Device: wound dressing containing silk sericin A scaffold from silk sericin-polyvinyl alcohol-glycerin blending are applied on one half of the skin graft donor site Device: fine mesh gauze impregnated with paraffin and 0.5%chlorhexidine acetate (Bactigras, Smith\&Nephew, London, UK) are applied on the other half of the skin graft donor site

Trial Locations (1)

10330

Chulalongkorn Hospital, Bangkok

All Listed Sponsors
lead

Chulalongkorn University

OTHER

NCT01539980 - Clinical Study on Silk Sericin Wound Dressing for Split-thickness Skin Graft Donor Sites Treatment | Biotech Hunter | Biotech Hunter